Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 21, 2020

SELL
$16.28 - $25.63 $79,788 - $125,612
-4,901 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$19.57 - $23.52 $95,912 - $115,271
4,901 New
4,901 $114,000
Q3 2018

Nov 05, 2018

SELL
$19.97 - $21.96 $299 - $329
-15 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$20.16 - $24.68 $302 - $370
15 New
15 $0

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $4.83B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.